ArticleDie Ophthalmologie2026
[Epidemic keratoconjunctivitis: treatment of subepithelial infiltrates and topographic parameters of the cornea in the postinfection course].
Article in Die Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpidemic keratoconjunctivitis (EKC) is a highly contagious eye infection caused by adenoviruses. The treatment remains challenging due to limited efficacy and the potential for long-term complications. This study aimed to evaluate the impact of different treatment approaches on the persistence and resolution of nummular keratitis as well as to assess corneal topographic parameters during the posttreatment course. PATIENTS AND
methodsThis real-world analysis examined data from 120 patients (146 eyes) with clinically suspected EKC. The patients were divided into three groups based on the initial treatment: (1) antiviral agent with an antibiotic, (2) additional corticosteroids or (3) hyaluronic acid only. In the chronic phase patients were classified into one of four groups depending on the treatment: (A) corticosteroids, (B) cyclosporine, (C) a combination of corticosteroids and cyclosporine or (D) hyaluronic acid only. Clinical parameters, such as the prevalence of nummular keratitis, tear film characteristics and keratometry were monitored for up to 1 year.
resultsAmong the 146 examined eyes 27.4% exhibited nummular keratitis at the initial diagnosis. After 6 weeks the prevalence increased to 45.2% then decreased to 39% at 6 months and further declined to 9.5% after 1 year (p = 0.01). Early corticosteroid treatment at the time of first diagnosis was associated with chronic persistence of nummular keratitis. In contrast, a delayed initiation of combination treatment with corticosteroids and cyclosporine, initiated 6 weeks after diagnosis proved to be the most effective. This approach led to the complete resolution of nummular keratitis after 1 year. Monotherapy, particularly cyclosporine alone, showed lower efficacy. Astigmatism fluctuated over the course of up to 1 year following EKC infection.
conclusionDelayed initiation of combination treatment with corticosteroids and cyclosporine demonstrated long-term effectiveness and should be considered as the primary treatment for nummular keratitis. Corneal topographic parameters remained largely stable during the postinfection course. These findings support the superior efficacy of combination treatment in reducing the recurrence of nummular keratitis and stabilizing corneal topography.
Indexed as
Identifiers
41396362What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.